FLEXNAV DELIVERY SYSTEM
Report
- Report Number
- 2135147-2026-02010
- Event Type
- Death
- Date Received
- March 30, 2026
- Date of Event
- March 3, 2026
- Report Date
- May 6, 2026
- Manufacturer
- ABBOTT MEDICAL
- Product Code
- NPT
- UDI-DI
- 05415067031372
- PMA / PMN Number
- P190023
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
THE DEVICE WILL NOT BE RETURNED FOR EVALUATION, THE DEVICE WAS REPORTEDLY DISCARDED. INVESTIGATION IS NOT YET COMPLETE. A FOLLOW-UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION.
AN EVENT OF DIFFICULT TO ADVANCE WAS REPORTED. A RETURNED DEVICE ASSESSMENT COULD NOT BE PERFORMED AS THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE DEVICE HISTORY RECORD WAS REVIEWED TO ENSURE THAT EACH MANUFACTURING AND INSPECTION OPERATION WAS PERFORMED, AND THE PRODUCT MET ALL SPECIFICATIONS. ADDITIONALLY, THE LOT WAS REVIEWED FOR SIMILAR COMPLAINTS, AND THERE IS NO INDICATION OF A LOT-SPECIFIC PRODUCT ISSUE. BASED ON THE AVAILABLE INFORMATION, THE CAUSE OF THE REPORTED ADVANCEMENT ISSUE COULD NOT BE CONCLUSIVELY DETERMINED. IT IS POSSIBLE PROCEDURAL AND/OR PATIENT CIRCUMSTANCES CONTRIBUTED TO THE REPORTED ADVANCEMENT DIFFICULTY; HOWEVER, THIS CANNOT BE CONFIRMED. THE REPORTED UNEXPECTED MEDICAL INTERVENTIONS ARE DUE TO CASE SPECIFIC CIRCUMSTANCES, AS A CPR WAS PERFORMED AND MEDICATION WAS PROVIDED. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.
IT WAS REPORTED THAT ON (B)(6) 2026, A 25MM NAVITOR VISION VALVE WAS SELECTED FOR IMPLANT USING A SMALL FLEXNAV DELIVERY SYSTEM (DS). PRIOR TO THE PROCEDURE, THE PATIENT WAS IN A STABLE CONDITION. THE PATIENT HAD SEVERE CALCIFIED ANATOMY IN THE ASCENDING AND ABDOMINAL AORTA. PRE-IMPLANT BALLOON AORTIC VALVULOPLASTY (PRE-BAV) WAS PERFORMED USING A 17MM, NON-ABBOTT BALLOON. DURING THE PROCEDURE, THE DS WAS UNABLE TO ADVANCE THE SINOTUBULAR JUNCTION (STJ) CALCIUM DEPOSITS, SO IT WAS RETRACTED DOWN TO THE ABDOMINAL AORTA. DURING THE TIME OF DISCUSSION ON CONTINUING WITH THE NEXT STEPS, THE PATIENT BECAME HYPOTENSIVE AND A CARDIOPULMONARY RESUSCITATION (CODED) WAS PERFORMED, AND MEDICATION (UNSPECIFIED) WAS ADMINISTERED, SUBSEQUENTLY THE PATIENT WAS PRONOUNCED TO BE DECEASED. THE PHYSICIAN STATED THAT HE DOES NOT BELIEVE IT WAS A PRODUCT ISSUE OTHER THAN NOT BEING ABLE TO CROSS CALCIFIED STJ. ADDITIONALLY, HE STATED THAT THE ADVERSE CONSEQUENCES WERE DUE TO PATIENT'S ANATOMY, FRAILTY, AND BEING HIGH RISK FOR THE PROCEDURE. THE OFFICIAL CAUSE OF DEATH WAS CIRCULATORY COLLAPSE.
IT WAS REPORTED THAT ON (B)(6) 2026, A 25 MM NAVITOR VISION VALVE WAS SELECTED FOR IMPLANT USING A SMALL FLEXNAV DELIVERY SYSTEM (DS). PRIOR TO THE PROCEDURE, THE PATIENT WAS IN A STABLE CONDITION. THE PATIENT HAD SEVERE CALCIFIED ANATOMY IN THE ASCENDING AND ABDOMINAL AORTA. PRE-IMPLANT BALLOON AORTIC VALVULOPLASTY (PRE-BAV) WAS PERFORMED USING A 17 MM, NON-ABBOTT BALLOON. DURING THE PROCEDURE, THE DS WAS UNABLE TO ADVANCE THE SINOTUBULAR JUNCTION (STJ) CALCIUM DEPOSITS, SO IT WAS RETRACTED DOWN TO THE ABDOMINAL AORTA. DURING THE TIME OF DISCUSSION ON CONTINUING WITH THE NEXT STEPS, THE PATIENT BECAME HYPOTENSIVE AND A CARDIOPULMONARY RESUSCITATION (CODED) WAS PERFORMED, AND MEDICATION (UNSPECIFIED) WAS ADMINISTERED, SUBSEQUENTLY THE PATIENT WAS PRONOUNCED TO BE DECEASED. THE PHYSICIAN STATED THAT HE DOES NOT BELIEVE IT WAS A PRODUCT ISSUE OTHER THAN NOT BEING ABLE TO CROSS CALCIFIED STJ. ADDITIONALLY, HE STATED THAT THE ADVERSE CONSEQUENCES WERE DUE TO PATIENT'S ANATOMY, FRAILTY, AND BEING HIGH RISK FOR THE PROCEDURE. THE OFFICIAL CAUSE OF DEATH WAS CIRCULATORY COLLAPSE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 127523 | FLEXNAV DELIVERY SYSTEM | AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED | NPT | ABBOTT MEDICAL | FNAV-DS-SM | 10902420 | 05415067031372 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |